Cost–Utility Analysis of Antihemophilic Factor Rfviii-Fs for Secondary Prophylaxis Vs on-Demand Therapy In Severe Haemophilia A In Italy
Abstract
Authors
A Tagliaferri A Coppola S Amoresano A Aiello A D’Ausilio M Toumi
A Tagliaferri A Coppola S Amoresano A Aiello A D’Ausilio M Toumi
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now